Innovative Insurance to Improve US Patient Access to Cell and Gene Therapy
{{output}}
Policy Points Cell and gene therapies (CGTs) offer treatment for rare and oftentimes deadly disease, but their prices are high, and payers may seek to limit spending. Total annual costs of covering all existing and expected CGTs for the entire US population 20... ...
